GRAY Insider Trading

49.94% of Graybug Vision stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Graybug Vision Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/13/2023	BML Capital Management LLC	1,235,943	$0.62M	0.6%	N/A	5.733%
5/4/2022	Advisor Group Holdings Inc.	19,000	$0.74M	0.0%	N/A	0.089%
2/14/2022	GSA Capital Partners LLP	86,199	$0.16M	0.0%	N/A	0.404%
11/12/2021	Johnson & Johnson	49,547	$0.16M	0.0%	N/A	0.233%
9/17/2021	Virtu Financial LLC	65,899	$0.36M	0.0%	+11.4%	0.310%
8/16/2021	Squarepoint Ops LLC	17,580	$95K	0.0%	N/A	0.083%
8/16/2021	Cubist Systematic Strategies LLC	19,529	$0.11M	0.0%	-67.9%	0.093%
8/16/2021	Morgan Stanley	609,412	$3.31M	0.0%	-34.3%	2.894%
8/16/2021	Charles Schwab Investment Management Inc.	23,432	$0.13M	0.0%	-35.6%	0.111%
8/16/2021	State Street Corp	41,173	$0.22M	0.0%	-61.9%	0.196%
8/13/2021	Northern Trust Corp	11,957	$65K	0.0%	-83.1%	0.057%
8/13/2021	Geode Capital Management LLC	70,382	$0.38M	0.0%	-43.0%	0.334%
8/13/2021	Vanguard Group Inc.	430,387	$2.34M	0.0%	+80.2%	2.044%
8/12/2021	Ergoteles LLC	17,700	$96K	0.0%	N/A	0.084%
5/19/2021	Virtu Financial LLC	59,180	$0.33M	0.0%	N/A	0.281%
5/19/2021	Grosvenor Holdings L.L.C.	216,458	$1.20M	0.1%	N/A	1.028%
5/18/2021	Morgan Stanley	927,708	$5.15M	0.0%	+18,596.3%	4.406%
5/18/2021	Orbimed Advisors LLC	4,163,347	$23.11M	0.2%	-7.0%	19.773%
5/18/2021	Cubist Systematic Strategies LLC	60,819	$0.34M	0.0%	N/A	0.289%
5/18/2021	Jane Street Group LLC	20,775	$0.12M	0.0%	N/A	0.099%
5/17/2021	Walleye Trading LLC	32,802	$0.18M	0.0%	N/A	0.156%
5/17/2021	Price T Rowe Associates Inc. MD	206,425	$1.15M	0.0%	N/A	0.980%
5/17/2021	Walleye Capital LLC	74,799	$0.42M	0.0%	N/A	0.355%
5/17/2021	Nuveen Asset Management LLC	15,923	$88K	0.0%	+48.5%	0.076%
5/17/2021	Novo Holdings A S	209,748	$1.16M	0.0%	N/A	0.996%
5/17/2021	Goldman Sachs Group Inc.	30,710	$0.17M	0.0%	N/A	0.146%
5/14/2021	Brown Advisory Inc.	27,799	$0.15M	0.0%	N/A	0.132%
5/14/2021	AlpInvest Partners B.V.	183,430	$1.02M	0.5%	N/A	0.871%
5/14/2021	Occudo Quantitative Strategies LP	30,541	$0.17M	0.0%	N/A	0.145%
5/14/2021	XTX Topco Ltd	14,032	$78K	0.0%	N/A	0.067%
5/13/2021	Bessemer Group Inc.	26,941	$0.15M	0.0%	N/A	0.128%
5/12/2021	Northern Trust Corp	70,698	$0.39M	0.0%	-4.9%	0.336%
5/12/2021	Geode Capital Management LLC	123,371	$0.68M	0.0%	+10.7%	0.586%
5/12/2021	JPMorgan Chase & Co.	126,203	$0.70M	0.0%	+587.8%	0.599%
5/11/2021	New York State Common Retirement Fund	5,851	$32K	0.0%	+58.1%	0.028%
5/10/2021	Bank Julius Baer & Co. Ltd Zurich	43,411	$0.24M	0.0%	N/A	0.206%
5/7/2021	BlackRock Inc.	322,579	$1.79M	0.0%	+4.6%	1.532%
5/7/2021	American International Group Inc.	111,571	$0.62M	0.0%	+2,839.2%	0.530%
5/6/2021	Johnson & Johnson Innovation JJDC Inc.	49,547	$0.28M	0.0%	N/A	0.235%
4/20/2021	Alta Wealth Advisors LLC	10,771	$60K	0.1%	N/A	0.051%
2/24/2021	Alyeska Investment Group L.P.	29,061	$0.84M	0.0%	-61.6%	0.139%
2/19/2021	JPMorgan Chase & Co.	18,349	$0.53M	0.0%	N/A	0.087%
2/16/2021	Alyeska Investment Group L.P.	29,061	$0.84M	0.0%	-61.6%	0.139%
2/16/2021	Nuveen Asset Management LLC	10,721	$0.31M	0.0%	N/A	0.051%
2/16/2021	Charles Schwab Investment Management Inc.	39,127	$1.14M	0.0%	N/A	0.187%
2/13/2021	American International Group Inc.	3,796	$0.11M	0.0%	N/A	0.018%
2/11/2021	Northern Trust Corp	74,305	$2.16M	0.0%	N/A	0.354%
2/11/2021	Citigroup Inc.	1,211	$35K	0.0%	N/A	0.006%
2/9/2021	Wells Fargo & Company MN	3,391	$98K	0.0%	N/A	0.016%
2/9/2021	Bank of New York Mellon Corp	16,322	$0.47M	0.0%	N/A	0.078%
2/8/2021	New York State Common Retirement Fund	3,700	$0.11M	0.0%	N/A	0.018%
2/5/2021	BlackRock Inc.	308,525	$8.96M	0.0%	+197.6%	1.471%
2/4/2021	State of Wisconsin Investment Board	9,000	$0.26M	0.0%	N/A	0.043%
1/25/2021	Strs Ohio	1,600	$46K	0.0%	N/A	0.008%
12/30/2020	Deerfield Management Company L.P. Series C	5,281,713	$67.13M	1.3%	N/A	25.176%
11/6/2020	BlackRock Inc.	103,680	$1.32M	0.0%	N/A	0.516%

Data available starting January 2016

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

Today's Range

Now: $2.76

$2.76

$2.89

50 Day Range

MA: $3.46

$2.70

$4.80

52 Week Range

Now: $2.76

$5.00

$22.12

Volume

68,617 shs

Average Volume

2,165 shs

Market Capitalization

$4.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.